- Location
research deal
"-
Berg Has Signed a Cooperative Research and Development Agreement
Aug 13, 2013Berg has signed a cooperative research and development agreement with the US Department of Defense, to advance prostate cancer research. The Uniformed Services University of the Health Sciences' (USU) Center for Prostate Disease Research ...
Tags: Berg, Prostate Cancer Research
-
UCB Has Signed a Research Deal with ConfometRx for The Discovery of New Drugs
Feb 26, 2013Belgium-based biopharmaceutical company UCB has signed a research deal with ConfometRx for the discovery of new drugs. Under the deal, UCB and ConfometRx will leverage structural biology to gain insight into G-protein coupled receptor ...
Tags: drug discovery, biopharmaceutical, UCB
-
Morphosys and Heptares to Develop Antibody Therapeutics Against GPCRs
Feb 20, 2013MorphoSys and Heptares Therapeutics have signed a research deal to develop antibody therapeutics against G protein-coupled receptors (GPCRs). According to the deal, Heptares will produce stabilized receptors (StaRs) for MorphoSys proposed ...
Tags: antibody therapeutics, Heptares Therapeutics, GPCR disease
-
Genoa and McMaster Partnered to Characterize in Vivo Advantages and Potential Impact
Jan 17, 2013Genoa Pharmaceuticals and McMaster University have partnered to characterize the in vivo advantages and potential clinical impact of Genoa's inhaled GP-101 (aerosol pirfenidone) for the treatment of idiopathic pulmonary fibrosis (IPF). ...
Tags: Pharmaceuticals, clinical impact, exploring mechanisms
-
Santaris Pharma and miRagen Therapeutics Have Extended Their Research Deal
Jan 14, 2013Santaris Pharma and miRagen Therapeutics have extended their research deal to discover and develop LNA-drugs against disease causing microRNAs. The agreement allows miRagen to gain a non-exclusive license to the miRNA therapeutics field ...
-
COTI Signed a Drug Discovery Deal to Use CHEMSAS Drug Discovery System
Dec 10, 2012Critical Outcome Technologies (COTI) has signed a drug discovery deal with an undisclosed pharmaceutical company to use its CHEMSAS drug discovery system for the identification of small molecules. COTI will look after the discovery, ...
Tags: COTI, new drug research, CHEMSAS
-
AET BioTech and BioXpress Therapeutics Signed a Research Deal
Nov 28, 2012AET BioTech and BioXpress Therapeutics have signed a research deal for the development of a biosimilar version of the TNF inhibitor MAb Adalimumab. Under the agreement, both the companies will be responsible for the development, ...
Tags: AET BioTech, BioXpress Therapeutics, TNF Inhibitor, research deal
